Alzheimer’s disease and related dementias clinical trials
Brain & nerves
94 trials are recruiting, according to ClinicalTrials.gov.
Checked against the registry on 5 October 2026. Listing a trial here is not a recommendation; taking part is voluntary and each study team decides who is eligible.
Home-Based Brain Stimulation for Motoric Cognitive Risk Syndrome
Ages 65 Years to 90 Years · 2 sites · Hebrew SeniorLife
Details and how to check if you qualify · NCT06821568 on ClinicalTrials.gov
Advancing Ethical Goals In Society Trial
Ages 65 Years to no maximum · 2 sites · Tufts Medical Center
Web-Based Insomnia Treatment for Spousal Dementia Caregivers (SHUTi-DC)
Ages 18 Years to no maximum · 0 sites · University of Missouri-Columbia
An Insole and Ankle Device for Monitoring Cognitive Decline in Individuals at Risk for Alzheimer's Disease and/or Alzheimer's Disease Related Dementias (AD/ADRD)
Ages 55 Years to no maximum · 1 site · HealthPartners Institute
Improv Music Therapy for Older Adults
Ages 60 Years to no maximum · 1 site · University of California, San Francisco
A Mobile Informatics Solution to Assist Caregivers in Care Coordination and Monitoring Social Engagement
Ages 18 Years to no maximum · 1 site · University of Minnesota
To Evaluate the Long-term Safety and Tolerability of Acoramidis in Participants With Newly Diagnosed ATTR-CM (ACT-EARLY OLE)
Ages 18 Years to no maximum · 0 sites · Eidos Therapeutics, a BridgeBio company
Dyadic Life Review Intervention for Older Patients With Advanced Cancer and Alzheimer's Disease and Related Dementias and Their Caregivers
Ages 50 Years to no maximum · 1 site · University of Rochester
Cognition and Affective Research in China
Ages No minimum to no maximum · 1 site · Xuanwu Hospital, Beijing
Jigsawdio Multisensory Platform for People With Mild Cognitive Impairment, Alzheimer's Disease, or Related Dementias
Ages 60 Years to no maximum · 2 sites · Callahan-Young LLC DBA Jigsawdio
GAPcareAD: A Brief Emergency Department Intervention to Address Post-Fall Care Needs of Persons Living With Dementia and Care Partners
Ages 65 Years to no maximum · 0 sites · University of Colorado, Denver
Probiotic Milk Drink for Gut and Brain Health in Older Adults and Caregivers
Ages 18 Years to no maximum · 1 site · University of South Florida
Mild Cognitive Impairment Community Screening and Early Intervention Via Stem Cell Therapy and Wearable Brain Computer Interface Device.
Ages 55 Years to no maximum · 1 site · Noah Tech, Corp.
Remote Monitoring in Progressive Supranuclear Palsy (PSP)
Ages 18 Years to 89 Years · 2 sites · Massachusetts General Hospital
Veech Ketone Ester to Support Brain Energy in Mild Cognitive Impairment and Early Alzheimer's Disease
Ages 21 Years to no maximum · 1 site · University of Pennsylvania
Presence of Anti-RACH Antibodies and Neurocognitive Disorder in Myasthenic or Alzheimers's Patients.
Ages 18 Years to no maximum · 1 site · Centre Hospitalier Universitaire de Nice
VICA: A Virtual Care Assistant for Dementia Caregivers
Ages 21 Years to no maximum · 1 site · Indiana University
Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis
Ages 18 Years to 80 Years · 1 site · Eidos Therapeutics, a BridgeBio company
REPAIR Sleep Study
Ages 18 Years to no maximum · 0 sites · Emory University
Randomized Controlld Trial of Dementia Education Resources for Action
Ages 18 Years to no maximum · 1 site · George Mason University
CommunityRx-Dementia + Peer Navigation (CRxDpeer)
Ages 18 Years to no maximum · 0 sites · University of Chicago
High-Velocity Resistance Training for Brain Blood Flow and Cognitive Function in Older Adults
Ages 60 Years to 79 Years · 0 sites · University of Illinois at Chicago
Designing Care Management for Hospice Transitions for Persons Living With Advanced Dementia
Ages 18 Years to no maximum · 1 site · New York University
Financial Counseling for Dementia Family Caregivers in Early and Middle Adulthood
Ages 25 Years to 55 Years · 1 site · University of Utah
Prospective Observational Study of the Relationship Between Sociodemographic Factors, Blood-based Biomarkers and Psychiatric Symptoms in Neurodegenerative Diseases and Mental Disorders
Ages 18 Years to no maximum · 1 site · Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Evaluate the Use of [18F]-APN-1607 PET in Subjects With AD-related Cognitive Impairment and Subjects With Normal Cognitive Function
Ages 50 Years to no maximum · 2 sites · JYAMS PET Research & Development Limited
Transcranial Photobiomodulation (tPBM) in Alzheimer's Disease Study
Ages 55 Years to 89 Years · 1 site · Cedars-Sinai Medical Center
Positive Psychology for Early Cognitive Decline: Effects on Cognitive and Brain Function
Ages No minimum to no maximum · 1 site · Aristotle University Of Thessaloniki
Biofluid Research on Age-Related or Inherited Neurodegeneration
Ages 18 Years to no maximum · 1 site · University of Pennsylvania
Feasibility of Wearables in Dementia Care in Rural Taiwan
Ages No minimum to no maximum · 1 site · China Medical University Hospital
Efficacy of Gamma Auditory Stimulation for Cognitive Decline in Older Adults (Study 1)
Ages 60 Years to no maximum · 1 site · Chang Gung Memorial Hospital
Evaluating the Efficacy and Safety of PROSOMNIA Sleep Therapy™ in Patients With Sleep Deprivation and Chronic Insomnia
Ages 18 Years to 65 Years · 1 site · Nyree Penn
The Role of METhanogens in the PROgression Of Parkinson's Disease and Related Neurological Conditions
Ages 55 Years to no maximum · 1 site · University of Cambridge
Daridorexant to Prevent Post-cardiotomy Delirium
Ages 60 Years to no maximum · 1 site · University of Rochester
Testing & Refinement of CarePair: An Assessment and Referral Platform to Support Family Caregivers of Alzheimer's Disease and Related Dementias.
Ages 18 Years to no maximum · 1 site · University of Southern California
Evaluation of the Effectiveness of Virtual Reality Headsets With Hypnotic Scenarios for Hygiene Care in Patients With Alzheimer's Disease or Related Disorders With Behavioral Disturbances
Ages 18 Years to no maximum · 1 site · Centre Hospitalier Universitaire, Amiens
Mitochondrial Function and Metabolomic Profile in Alzheimer's Disease and Related Dementias
Ages 18 Years to no maximum · 1 site · Centre Hospitalier Universitaire de Nice
The BRAIN App (Phase 2 SBIR)
Ages 65 Years to no maximum · 1 site · Hopeful Aging
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Ages 18 Years to 75 Years · 104 sites · Eidos Therapeutics, a BridgeBio company
Feasibility of Using the Gatorade Sports Science Institute (GSSI) Labs App for Hydration Related Outcomes
Ages 18 Years to 65 Years · 1 site · PepsiCo Global R&D
Study to Detect Dendritic Cell Recruitment in Human Retina
Ages 55 Years to 80 Years · 0 sites · MindImmune Therapeutics, Inc.
VR Pupillometry in Cognitive Impairment
Ages 18 Years to 80 Years · 1 site · Max-Planck-Institute of Psychiatry
Feasibility and Interest of the 3D Ephemeris for Temporal Orientation in Alzheimer's: Pilot Study
Ages 65 Years to no maximum · 1 site · Assistance Publique - Hôpitaux de Paris
Blood Biomarkers for Alzheimer Disease and Neuro-injury to Estimate the Association With Cognitive/Functional Decline and Mortality in a Real-world Population of GERiatric Hospitalized Patients (BAD-GER)
Ages 65 Years to no maximum · 3 sites · Istituto Nazionale di Ricovero e Cura per Anziani
The DIAGNOSE CTE Research Project-II
Ages 50 Years to no maximum · 5 sites · Boston University
Connect-Home: Alzheimer's Disease and Related Dementias
Ages 19 Years to no maximum · 1 site · University of North Carolina, Chapel Hill
Development of Measures to Screen for Financial Hardship in Alzheimer's Disease and Dementia
Ages 18 Years to no maximum · 1 site · Fred Hutchinson Cancer Center
Early-Stage Partner in Care Living Alone Plus
Ages 60 Years to no maximum · 1 site · Arizona State University
Remote tDCS and Chair Yoga for Chronic Knee Pain in Alzheimer's Patients
Ages 60 Years to no maximum · 1 site · University of Arizona
Understanding Mechanisms of Synaptic Degeneration Underlying Clinical Symptoms in Patients With MDs and NDs.
Ages 40 Years to no maximum · 1 site · Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
[18F]ACI-19626 PET in TDP-43 Proteinopathies
Ages 40 Years to 70 Years · 1 site · AC Immune SA
Mindfulness to Enhance Cognitive Health in Latino Older Adults
Ages 65 Years to no maximum · 1 site · Washington University School of Medicine
Association of Transcranial Alternating Current Stimulation with Digital Cognitive Training for Cognitive Remediation in Older Adults
Ages 50 Years to no maximum · 1 site · Universidade Federal do Rio de Janeiro
A Study of CM383 in Patients With Alzheimer's Disease Related Mild Cognitive Impairment and Mild Alzheimer's Disease
Ages 50 Years to 85 Years · 1 site · Keymed Biosciences Co.Ltd
Feasibility of Using an App for Managing Phantom Limb Pain Associated with Combat Injury in Ukraine (PAMELA)
Ages 18 Years to no maximum · 5 sites · Winfried Meißner
Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
Ages 60 Years to 90 Years · 23 sites · GAP Innovations, PBC
Frailty Outcomes And Risk With Alzheimer's Related Dementia
Ages 65 Years to no maximum · 1 site · Aalborg University Hospital
Remote Sensing for ADRD-Specific Activities Identification in Older Adults
Ages 50 Years to no maximum · 1 site · University of Missouri-Columbia
Early Age-Related Hearing Loss Investigation (EARHLI)
Ages 55 Years to 75 Years · 1 site · Columbia University
OTC Hearing Aid and MCI
Ages 60 Years to 90 Years · 1 site · Northwestern University
The Peripheral Blood Multi-Omics Study on Sleep Loss
Ages 18 Years to 80 Years · 1 site · First Affiliated Hospital of Zhejiang University
Daily Goal Setting to Increase Everyday Physical Activity and Promote Cognitive Health in Midlife
Ages 30 Years to 70 Years · 1 site · Milton S. Hershey Medical Center
A Post Marketing Study in Participants With Early Alzheimer's Disease Treated With Lecanemab
Ages 18 Years to no maximum · 3 sites · Eisai Co., Ltd.
Premorbid Personality Profile of Patients With Cognitive and Behavioral Disorders
Ages 18 Years to no maximum · 1 site · Nantes University Hospital
Anxiety Sensitivity Treatment to Reduce Anxiety in Alzheimer's
Ages 60 Years to no maximum · 3 sites · Florida State University
Pan-Amyloid PET/CT in Various Amyloid-Related Disease
Ages 18 Years to 80 Years · 3 sites · Tianjin Medical University
The Nightlight Falls Prevention Study
Ages 18 Years to no maximum · 1 site · University of North Carolina, Chapel Hill
Goal Setting to Promote Physical Activity Adherence in Midlife Adults
Ages 45 Years to 65 Years · 1 site · Arizona State University
I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms
Ages 18 Years to no maximum · 2 sites · Indiana University
Investigation of Inflammation in Alzheimer's Disease and Related Dementias (ADRD) Using [11C]-CS1P1
Ages 50 Years to no maximum · 1 site · Washington University School of Medicine
Transcranial Magnetic Stimulation Treatment for Alzheimer's Disease
Ages 40 Years to 99 Years · 1 site · Massachusetts General Hospital
Intervention to Collect and Utilize Sexual Orientation and Gender Identity (SOGI) Information in Hospice
Ages 18 Years to no maximum · 1 site · University of Colorado, Denver
Comparison of Two Group Wellness Interventions for Individuals With Neurologic Conditions and Their Support Persons
Ages 18 Years to no maximum · 1 site · Kessler Foundation
NYSCF Scientific Discovery Biobank
Ages 30 Days to no maximum · 1 site · New York Stem Cell Foundation Research Institute
The Diabetes Prevention Program Outcomes Study AD/ADRD Project
Ages No minimum to no maximum · 27 sites · Marinella Temprosa
Natives Engaged in Alzheimers Research - 'Ike Kupuna
Ages 50 Years to 75 Years · 3 sites · University of Hawaii
Global Blood-Brain Barrier Disruption and Post-Stroke Cognitive Decline
Ages 18 Years to no maximum · 1 site · Johns Hopkins University
Assess Fibrin in Brains With AD/ADRD
Ages 55 Years to 90 Years · 1 site · Massachusetts General Hospital
Moving Yourself in Space and Time: MYSTIC
Ages 18 Years to 79 Years · 1 site · Emory University
Neurofilament Light Chains and Cognitive Impairment in Chronic Psychiatric Disease
Ages 45 Years to 80 Years · 2 sites · Hôpital le Vinatier
Cholinergic Integrity in Down Syndrome in Association With Aging, Alzheimer's Disease Pathology, and Cognition
Ages 18 Years to 55 Years · 1 site · Vanderbilt University Medical Center
Study on the Relationship Between Peripheral Blood miRNA and Risk and Severity of Alzheimer's Disease
Ages 65 Years to no maximum · 1 site · Jiajie Chen
Targeting Neuroinflammation as a Contributing Pathology in Alzheimer's Disease Dementia and Related Dementias
Ages 60 Years to no maximum · 1 site · Val Lowe
TAS Test: Online Motor-cognitive Tests for Early Detection of Alzheimer's Disease
Ages 50 Years to no maximum · 1 site · University of Tasmania
Nabilone for Agitation Blinded Intervention Trial
Ages 55 Years to no maximum · 6 sites · Sunnybrook Health Sciences Centre
MR Evaluation of Cerebrospinal Fluid (CSF) Dynamics
Ages 18 Years to no maximum · 1 site · Mayo Clinic
Retinal Imaging in Neurodegenerative Disease
Ages 18 Years to no maximum · 1 site · Duke University
Aerobic Exercise for Older Adults at Increased Risk of Alzheimer's Disease and Related Dementias
Ages 50 Years to 80 Years · 1 site · University of Calgary
Motor Slowing and Its Lesion-related Correlates in Alzheimer's Disease
Ages 40 Years to 85 Years · 1 site · Centre Hospitalier Universitaire, Amiens
Predictive Factors and Autonomy Level Change
Ages 65 Years to no maximum · 2 sites · Hospices Civils de Lyon
Brain Health Registry: An Online Registry to Identify and Assess Subjects for Brain Research
Ages 18 Years to no maximum · 1 site · University of California, San Francisco
Beta Amyloid PET/CT in Various Aβ-Related Disease
Ages 18 Years to 80 Years · 4 sites · Tianjin Medical University
Development of IPS from Donated Somatic Cells of Patients with Neurological Diseases
Ages 18 Years to no maximum · 1 site · Hadassah Medical Organization
Alzheimer's Disease Genetics Study
Ages 18 Years to no maximum · 1 site · Indiana University
More: Acne clinical trials · Cannabis use disorder clinical trials · Chronic hives (chronic urticaria) clinical trials · COPD (chronic obstructive pulmonary disease) clinical trials · Depression (major depressive disorder) clinical trials · Moderately to severely active crohn's disease clinical trials